At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
HeartLogic ON +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multiple Cardiac Sensors for the Management of Heart Failure
In Brief
A clinical study evaluating HeartLogic ON and HeartLogic OFF for Heart Failure, Congestive. Completed, enrolled 200 participants across 30 sites in 3 countries.
Detailed Summary
The MANAGE-HF study is a multi-center, global, prospective, open label, multi-phase trial intended to evaluate the clinical efficacy of the HeartLogic heart failure diagnostic feature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Congestive
CountriesFrance, Germany, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartAug 2017
Primary CompletionJul 2020
TodayJul 2026
First PostedAug 3, 2017
Enrollment StartAug 30, 2017
Primary CompletionJul 21, 2020
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 8.9 years ago
Interventions
HeartLogic ONdevice
Remote management of patients with CRT-D or ICD devices and the HeartLogic diagnostic feature turned OFF
HeartLogic OFFdevice
Remote management of patients with CRT-D or ICD devices and the HeartLogic diagnostic feature turned ON